BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.
about
The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expressionLoss of BubR1 acetylation causes defects in spindle assembly checkpoint signaling and promotes tumor formation.Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis.Predictive and prognostic values of Tau and BubR1 protein in prostate cancer and their relationship to the Gleason score.Partial Hepatectomy in Acetylation-Deficient BubR1 Mice Corroborates that Chromosome Missegregation Initiates Tumorigenesis.ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survivalMad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.Requirement for BUB1B/BUBR1 in tumor progression of lung adenocarcinomaPredictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancerBubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9.Targeting aneuploid cancer cells.Elevated BUBR1 expression is associated with poor survival in early breast cancer patients: 15-year follow-up analysis.BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.Immunohistochemical expression of budding uninhibited by benzimidazole related 1 in leukoplakia and oral squamous cell carcinoma.Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation.BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival.
P2860
Q28743982-045C2C22-B4A8-4E72-B844-7C66968345CAQ30541696-40468926-88F3-430A-87E8-DDD9AD94D5D5Q33851325-09C1E5E7-2831-4AD3-85D5-A80BDFA9F60EQ34615748-3059ED66-83CC-415E-8717-279814BFF357Q34839217-00477CC4-D30E-4CAC-A58D-AD85CA04819EQ35006761-34006787-B7F4-48EF-BA99-0EE45032CCB9Q35497999-347FDDE9-1D1D-4B0E-8E71-16709D1803D2Q35591891-8A9BD47A-7B24-4B82-80FF-90D02BCDE910Q35854162-88F8DAE4-A10E-4BD6-BFEE-22EE8C9B2EDEQ35902482-5473F707-824F-435B-B824-A916A666B059Q37840163-BC7FDE21-BD80-40F3-81F0-E6B0CCE59FE9Q40125955-617A8639-857B-49EF-A184-6F6A7C7A4BE7Q40756333-1A1E7103-96D1-4EF4-8BC4-A15C7D00B7B7Q41188225-5A73DAFD-193A-4242-B62F-5D4E988F44F9Q46083335-2C7E6AC9-5AF1-4D8B-8361-9F94119FB6B5Q54212025-C931A8BD-AF27-4E43-83C8-D3A4089B8F97Q54633575-0CECE39B-E9D7-4A39-890C-DB06A2B5AB20
P2860
BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BubR1 as a prognostic marker f ...... in epithelial ovarian cancers.
@en
BubR1 as a prognostic marker f ...... in epithelial ovarian cancers.
@nl
type
label
BubR1 as a prognostic marker f ...... in epithelial ovarian cancers.
@en
BubR1 as a prognostic marker f ...... in epithelial ovarian cancers.
@nl
prefLabel
BubR1 as a prognostic marker f ...... in epithelial ovarian cancers.
@en
BubR1 as a prognostic marker f ...... in epithelial ovarian cancers.
@nl
P2093
P2860
P356
P1476
BubR1 as a prognostic marker f ...... in epithelial ovarian cancers.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605161
P407
P577
2009-07-14T00:00:00Z
P5875
P6179
1015971174